~~<i id='0683980B48'><strike id='0683980B48'><tt id='0683980B48'><pre id='0683980B48'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：Wikipedia 2025-10-01 21:09:39 - browse：7793

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： U.K. Biobank has 500,000 peoples' genome sequences available

leisure time

entertainment

focus

Wikipedia

focus

WhenProzacfirstenteredthepsychiatrysceneininthelate’80s,theprofessionwasstillFreud’sterritory.Manyco

WSS

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

30 years of 'Listening to Prozac'

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

explore

hotspot

leisure time

Moonlake's readout produced a cash windfall. Risks remain

U.K. Biobank has 500,000 peoples' genome sequences available

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What don’t we know about an Alzheimer’s drug side effect?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Virginia high school admissions case could be legal follow

Cigna, Humana reportedly in talks to merge

entertainment

In medicine, common shorthands can shortchange care

In medicine, common shorthands can shortchange care

Diagnostic tests are hitting their mathematical limits

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

In medicine, common shorthands can shortchange care

Cigna, Humana reportedly in talks to merge

focus

focus

Wikipedia

focus